MetLife rewards research on secretases, toxic Aβ transmission.
By paring back calcium signaling, researchers prevented signs of Alzheimer’s in mice carrying a presenilin mutation. Could the strategy work in humans?
A single dose of a commonly prescribed antidepressant suppresses Aβ production in the human central nervous system.
Will an antibody signature make for a new Alzheimer’s diagnostic?
New NIH policies will require researchers to study male and female biology.
Tau and amyloid PET tracers demonstrate potential to sharpen the diagnosis of Alzheimer’s disease and frontotemporal dementias.
Resveratrol consumption failed to correlate with heart disease, inflammation, cancer, or even mortality in a community-based study. Are its benefits overstated?
Known for helping form new memories, new neurons may be just as important for erasing old ones.
Death receptor role in Alzheimer's disease looks less likely than was originally thought following a high-profile paper in 2009.
A gene already well known to counteract aging appears to improve cognition.
Deep-brain stimulation of the nucleus basalis of Meynert appeared safe and tolerable for Alzheimer’s patients.
Researchers are increasingly branching out from their old focus on Aβ and tau to understand how these proteins intersect with physiological processes and new genetic regulatory mechanisms in the aging brain.
The overused adage of the fountain of youth rears its head again, as four new studies show how young blood rejuvenates old brain and muscle, pumping up the vasculature, stem cells, and restoring microglia’s appetite for waste products. Researcher are isolating the responsible factors, for example GDF11.
No filters selected